相关实验视频

Updated: Jul 14, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

塞尔珀卡提尼布用于局部晚期或转移性RET改变的固体瘤的成年患者

Dat Le¹, Bhavana Konda²

¹Department of Pharmacy, The Arthur G. James Cancer Hospital and Richard J. Solove Institute, The Ohio State University, Columbus, OH, USA.

Expert review of anticancer therapy

|October 5, 2023

概括

塞尔珀卡提尼布有效治疗转移过程中重新排列 (RET) 突变的癌症,显示持久的反应和良好的安全性. 目前正在进行的试验正在探索其在肺癌和甲状腺癌中最佳的应用.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
癌症遗传学癌症遗传学

背景情况:

在转移过程中重新排列的 (RET) 突变驱动癌症的发展.
塞尔珀卡提尼布是一种选择性RET抑制剂,具有已证明的抗瘤活性.
已批准的指示包括RET融合阳性NSCLC,髓性甲状腺癌和其他RET改变的固体瘤.

研究的目的:

审查selpercatinib的药理学,疗效,安全性和耐药性机制.
总结塞尔珀卡提尼布在RET突变癌症中的临床效用.

主要方法:

对selpercatinib的药理学进行文献综述.
对临床试验数据对疗效和安全性的分析.
对抗机制的检查.

主要成果:

塞尔珀卡提尼布显示出持久的抗瘤反应.
这种药物具有良好的安全性.
在各种RET改变的固体瘤中观察到有前途的活动.

结论:

塞尔珀卡提尼布是RET突变癌症的优秀治疗选择.
进一步的研究正在评估一线设置中的最佳序列.
它为RET改变的固体瘤患者提供了一个新的治疗途径.

关键词:

非小细胞肺癌的非小细胞肺癌.在RET的融合中,RET的融合.在RET-突变的情况下.塞尔珀卡提尼布 (selpercatinib) 是一种可以固体瘤是一种固体瘤.甲状腺癌是一种癌症.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...